Home › Funds › Strategic Wealth Investment Group, LLC › BSX

Strategic Wealth Investment Group, LLC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Strategic Wealth Investment Group, LLC reported holding 207,211 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 1.12% of its reported portfolio and ranking #36 among its reported holdings. Strategic Wealth Investment Group, LLC has disclosed BSX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)207.21K sh
Reported value held$9.04M
Portfolio Weight1.12%
First reportedQ3 2023
Last changeReduce
Updated2026-10-29

Last updated: 2026-10-29 · Source: SEC EDGAR Form 13F-HR

How Strategic Wealth Investment Group, LLC's BSX position evolved

Strategic Wealth Investment Group, LLC first disclosed a stake in BSX in Q3 2023 at 4,431 shares (US$234K). The position peaked in Q3 2025 at 132,940 shares, worth US$13.0M. Across 10 filings, Strategic Wealth Investment Group, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 207,211 shares valued at US$9.0M — a reduction of -2,404 shares quarter over quarter.. Notable position changes include a 46% trim in Q4 2024 (shares rose 13% over the following quarter), a 80% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.43K $233.96K New
Q4 2023 4.55K $262.98K Add
Q2 2024 4.46K $341.02K Reduce
Q3 2024 4.35K $366.09K Reduce
Q4 2024 2.33K $208.03K Reduce
Q3 2025 132.94K $12.98M New
Q4 2025 101.68K $9.70M Reduce
Q1 2026 116.61K $7.32M Add
Q2 2026 209.62K $8.95M Add
Q3 2026 207.21K $9.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Strategic Wealth Investment Group, LLC held BSX?

Strategic Wealth Investment Group, LLC has disclosed BSX holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is Strategic Wealth Investment Group, LLC's current position in BSX?

As of Q3 2026, Strategic Wealth Investment Group, LLC holds 207.21K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $9.04M, representing 1.12% of its reported portfolio and ranking #36.

Has Strategic Wealth Investment Group, LLC been buying or selling BSX?

In the latest 13F filing (Q3 2026), Strategic Wealth Investment Group, LLC reduced its position in BSX. The position peaked in Q3 2025 at 132.94K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.